Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging

Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging

Pulmonary infections caused by <i>Pseudomonas aeruginosa</i> (PA) represent the leading cause of pulmonary morbidity in adults with cystic fibrosis (CF). In addition to tobramycin, colistin, and aztreonam, levofloxacin has been approved in Europe to treat PA infections. Nevertheless, no...

Full description

Bibliographic Details
Main Authors: Carsten Schwarz, Claudio Procaccianti, Benjamin Mignot, Hosein Sadafi, Nicolas Schwenck, Xabier Murgia, Federico Bianco
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceutics
Subjects:
inhaled levofloxacin
<i>Pseudomonas aeruginosa</i>
cystic fibrosis
vibrating-membrane nebuliser
functional respiratory imaging
lung deposition
Online Access:https://www.mdpi.com/1999-4923/13/12/2051

Internet

https://www.mdpi.com/1999-4923/13/12/2051

Similar Items